Novartis
Company Score
+1.95Novartis International AG is a Swiss multinational pharmaceutical company. It is one of the largest pharmaceutical companies in the world and specialises in research, development and manufacturing of pharmaceuticals.
Novartis’ areas of business include pharmaceuticals, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses and animal health. It manufactures the drugs Clozaril, Voltaren, Tegretol, Diovan, Gleevec/Glivec, Neoral/Sandimmun, Femara, Ritalin, Lamisil, and many more.
Read about Novartis and its impact below.
Impact notes
Novartis commitment to Environmental Sustainability supported through four carbon-sink forestry projects around the world
B
Tue Mar 3rd, 2020 at 4:15pm
Novartis, one of the world’s largest pharmaceutical companies based in Switzerland aims to be carbon-neutral by 2025 and cut its level of 2016 carbon emissions level in half by 20302.
Novartis's impact on the Leprosy movement
Captain Planet
Thu Feb 20th, 2020 at 4:22pm
Leprosy is an ancient disease plaguing people from antiquity. The earliest written record of Leprosy can be "found on Egyptian papyrus [from] about 1550 B.C" [1;p1]. The disease is produced by a bacterium called Mycobacterium leprae, which while "not highly infectious... can cause severe and permanent damage to the skin, nerves, limbs and eyes if untreated"[2;p1]. Unfortunately, this ancient disease is still lurking among developing nations where people are most vulnerable.
Shifting from traditional drug research to data science to improve outcome: the new Novartis- Microsoft collaboration.
CarloAlb
Sat Nov 23rd, 2019 at 12:48pm
Improving healthcare standards and tackling growing medical needs with the most recent technology are major challenges for big pharmaceutical companies. Their achievements rely on company strategy and partnerships.
Novartis has set an internal carbon price to determine and mitigate the financial impact of GHG emissions from significant investments
janneyfoe
Mon Nov 4th, 2019 at 3:59pm
Novartis, a Swiss multinational pharmaceutical company, is one of the largest pharmaceutical companies by both market capitalization and sales. As such, it produces a significant amount of greenhouse gas emissions (GHG), contributing directly to climate change. To combat climat change and lower its carbon footprint, Novartis has set an internal carbon price of USD 100 per ton CO2e.
Novartis pioneer in Inclusive Business and BOP (bottom of the Pyramid) solutions
Henri FRAISSE
Mon Nov 4th, 2019 at 3:29pm
Novartis deployed a team to live in rural India for six months to understand how they could expand its business to the BOP (Bottom of the Pyramid). “What we found out is that for most of the products we had available, there was a real lack of health-seeking behaviour from people living in these villages, so there was a real need for health education and sanitation in these regions [1.p43].”